[Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the microbiologist].
Quentin
C
C
Laboratoire de microbiologie, Université de Bordeaux II.
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000201:enzymology* / Q000302:isolation & purification; D001991:Bronchitis / Q000188:drug therapy; D015169:Colony Count, Microbial; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000494:pharmacology; D006801:Humans; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology*; D018410:Pneumonia, Bacterial / Q000188:drug therapy; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000187:drug effects; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; D065093:beta-Lactamase Inhibitors; D019980:Amoxicillin-Potassium Clavulanate Combination; D001618:beta-Lactamases